Bernard, Servane F., Jord Orvoine, and René Groscolas. Glucose regulates lipid metabolism in fasting king penguins. Am J Physiol Regul Integr Comp Physiol 285: R313-R320, 2003. First published May 8, 2003 10.1152/ ajpregu.00094.2003.-This study aims to determine whether glucose intervenes in the regulation of lipid metabolism in long-term fasting birds, using the king penguin as an animal model. Changes in the plasma concentration of various metabolites and hormones, and in lipolytic fluxes as determined by continuous infusion of [2-3 H]glycerol and [1-14 C]palmitate, were examined in vivo before, during, and after a 2-h glucose infusion under field conditions. All the birds were in the phase II fasting status (large fat stores, protein sparing) but differed by their metabolic and hormonal statuses, being either nonstressed (NSB; n ϭ 5) or stressed (SB; n ϭ 5). In both groups, glucose infusion at 5 mg ⅐ kg Ϫ1 ⅐ min Ϫ1 induced a twofold increase in glycemia. In NSB, glucose had no effect on lipolysis (maintenance of plasma concentrations and rates of appearance of glycerol and nonesterified fatty acids) and no effect on the plasma concentrations of triacylglycerols (TAG), glucagon, insulin, or corticosterone. However, it limited fatty acid (FA) oxidation, as indicated by a 25% decrease in the plasma level of ␤-hydroxybutyrate (␤-OHB). In SB, glucose infusion induced an ϳ2.5-fold decrease in lipolytic fluxes and a large decrease in FA oxidation, as reflected by a 64% decrease in the plasma concentration of ␤-OHB. There were also a 35% decrease in plasma TAG, a 6.5-and 2.8-fold decrease in plasma glucagon and corticosterone, respectively, and a threefold increase in insulinemia. These data show that in fasting king penguins, glucose regulates lipid metabolism (inhibition of lipolysis and/or of FA oxidation) and affects hormonal status differently in stressed vs. nonstressed individuals. The results also suggest that in birds, as in humans, the availability of glucose, not of FA, is an important determinant of the substrate mix (glucose vs. FA) that is oxidized for energy production. lipolytic fluxes; fatty acid oxidation; stress; isotopic tracers; seabirds GLUCOSE AND FATTY ACIDS (FAs) are the two main metabolic substrates oxidized by animals for energy production. Interactions between these substrates are thought to control the extent of their respective oxidation, i.e., to control the reciprocal relation between glucose and FA oxidation. However, which of the two substrates, glucose or FA, is the primary regulator of this relation is a matter of debate (27, 36, 47) . Providing consistent explanations for some physiological and pathological circumstances such as fasting, obesity, and type 2 diabetes, the hypothesis of the glucose-FA cycle places great significance on FA availability as a factor controlling the fuel mix oxidized in humans and laboratory mammals (27, 28) . According to this hypothesis, high FA availability promotes FA oxidation, which in turn inhibits glucose oxidation (for a review, see Ref. 27). To the contrary, recent in vivo studies support the notion that in humans the availability of glucose determines substrate metabolism (37, 47). Supply of exogenous glucose was shown to inhibit FA release by adipose tissue under basal physiological conditions (49), after an 84-h fast (23), under euinsulinemic clamp (6), or during exercise (12). When FA availability was experimentally maintained, infusion of glucose also increased glucose oxidation and inhibited FA oxidation (37).
GLUCOSE AND FATTY ACIDS (FAs) are the two main metabolic substrates oxidized by animals for energy production. Interactions between these substrates are thought to control the extent of their respective oxidation, i.e., to control the reciprocal relation between glucose and FA oxidation. However, which of the two substrates, glucose or FA, is the primary regulator of this relation is a matter of debate (27, 36, 47) . Providing consistent explanations for some physiological and pathological circumstances such as fasting, obesity, and type 2 diabetes, the hypothesis of the glucose-FA cycle places great significance on FA availability as a factor controlling the fuel mix oxidized in humans and laboratory mammals (27, 28) . According to this hypothesis, high FA availability promotes FA oxidation, which in turn inhibits glucose oxidation (for a review, see Ref. 27) . To the contrary, recent in vivo studies support the notion that in humans the availability of glucose determines substrate metabolism (37, 47) . Supply of exogenous glucose was shown to inhibit FA release by adipose tissue under basal physiological conditions (49) , after an 84-h fast (23) , under euinsulinemic clamp (6) , or during exercise (12) . When FA availability was experimentally maintained, infusion of glucose also increased glucose oxidation and inhibited FA oxidation (37) .
Almost all our knowledge on in vivo glucose-FA interactions comes from studies in humans. How the substrate metabolism is controlled and what the importance of glucose availability is in this control in other vertebrates, especially birds, is poorly understood. Moreover, no study has examined the metabolic interactions between glucose and FA during prolonged fasting when the metabolic rate is sustained mainly by FA oxidation. Under these circumstances, chances of observing an effect of glucose on FA metabolism are maximized and the interindividual variability of carbohydrate and protein metabolism is minimized. Such a physiological situation can be mimicked using restricted-carbohydrate, high-fat diets or lipid emulsions (24) . However, this condition is encountered naturally in wild birds and mammals that spontaneously fast during their annual cycle. Among them are penguins (Spheniciforms), seabirds living in the antarctic and subantarctic regions. Penguins feed exclusively at sea and must fast on land for a period of up to 4 mo during breeding (16) . Their fasting physiology is well-defined and is representative of that of other birds (10) and to some extent of mammals (9) . Penguins adjust to prolonged fasting by mobilizing their fat stores, with about 90-96% of energy production coming from lipid oxidation while body proteins are spared (phase II of fasting) (10, 16) . Thanks to their large body size and their tameness, penguins offer the opportunity of conducting in vivo metabolic studies in wild animals. For example, the king penguin (Aptenodytes patagonicus) is the only bird on which lipolytic fluxes have been measured in vivo under field conditions in different fasting situations (2, 3) . Recently, we have suggested that in this bird, including during phase III of fasting, hormonal adjustments are oriented toward maintenance of glycemia rather than FA delivery (5) . This could suggest that in penguins glucose has a central place in fuel utilization.
Here we examine whether glucose is an important regulator of lipid metabolism in spontaneously fasting king penguins. The in vivo lipolytic, metabolic, and hormonal responses to infusion of glucose were investigated under field conditions during phase II of fasting. Lipolytic fluxes [rate of appearance (R a ) of nonesterified FA (NEFA) and of glycerol] were measured using tracer methodology before, during, and after a 2-h glucose infusion. Due to an unusual and unpredictable human activity in their vicinity, half of the birds were exposed to noise and were stressed at the time of the infusion experiment (see RESULTS and DISCUSSION). This gave us the opportunity of comparing the effect of glucose on lipid metabolism in two fasting situations where birds had the same energy reserves but different hormonal and metabolic statuses.
MATERIALS AND METHODS
Animals. This study was carried out at the breeding colony of the Baie du Marin (Possession Island, Crozet Archipelago; 46°25Ј S; 51°52Ј E) in February-March 2000. It was approved by the Ethics Committee of the Institut Français pour la Recherche et la Technologie Polaires and followed the Agreed Measures for the Conservation of Antarctic and Subantarctic Fauna. Ten male king penguins were identified from their song and caught while pairing at the onset of the ϳ25-day breeding fast and after having been fasting ashore for 1-3 days. Their average body mass (BM) at capture was 12.81 Ϯ 0.15 kg. One bird was caught every other day and then kept in an outdoor fenced area (3 ϫ 3 m) next to the colony under natural climatic conditions and within its thermoneutral range. They were habituated to captivity for 6 days, a time period known to be sufficient to suppress the confinement stress in penguins (19) . Given that infusion experiments were also performed every other day and begun 6 days after penning, throughout most of the study three birds were simultaneously present in the habituation pen. Because at capture birds had been fasting ashore for 1-3 days, the fasting duration at the time of the infusion experiment was ϳ8 days, which is more than the 2-to 3-day duration of the transition from the fed state to phase II reported for this species (11) . BM at the infusion experiment (ϳ11.5 kg, see RESULTS) was similar to that of free-living male king penguins at the onset of the first incubation shift, i.e., after about 8-10 days of fasting (31) . It was also 2.0 kg higher than the 9.5-to 10-kg BM measured at the phase II-phase III transition in breeding-fasting king penguins (8, 11) . Thus penguins at the time of the infusion experiment were in the phase II fasting status, which is characterized by a high contribution of lipids to energy production and body protein sparing (16) .
Over the 3-wk period of infusion experiments, the climatic conditions remained unchanged (air temperature 10-15°C, limited rainfalls, no storms). However, due to an unusual and unpredictable human activity in the vicinity of the fenced area on some days and throughout the whole study, it randomly occurred that 5 of the 10 animals were infused under noisy conditions (engines working at a 20-m distance, from 1-2 h before the beginning of the infusion experiment until its end). Other birds were infused under very quiet conditions. Although there was no direct human perturbation, not even visual contact, and although infused penguins behaved similarly in the two conditions, the measurement of basal plasma levels of hormone and metabolites (see RESULTS) showed that birds exposed to noise were stressed. Thus penguins in this study were separated into two groups (n ϭ 5 per group): nonstressed birds (NSB, quiet environment) and stressed birds (SB, noisy environment).
Catheterization and experimental setup. The infusion experiment on a bird lasted a total of 8 h and was separated into basal condition (3 h of tracer infusion without glucose), glucose infusion (2 h of tracer plus glucose infusion), and postglucose period (3 h of tracer infusion without glucose). On the day before the infusion experiment, the unanesthetized bird was cannulated with a polyethylene catheter (50-mm long; 1.1-mm OD) inserted percutaneously into the marginal vein of each flipper and extended with a 2-m-long section of tubing. Catheters were kept patent by infusion of saline (12 ml/day) using a small peristaltic pump. Catheterization of an artery for blood sampling for lipolytic flux measurements could not be adequately performed in field conditions. We assumed that any particular metabolism of the flipper (essentially feathers, bones, and tendons) is low and that the flipper venous blood reflects whole body metabolism. After catheterization, the birds were allowed to habituate to the experimental setup for 24 h. This setup was installed in a fenced area adjoining the habituation one and consisted of a small wooden pen (70 ϫ 70 cm) with one wall high enough to prevent us from being seen by the bird. Catheter extensions were placed into a balance lever system to avoid damage to the extensions or removal of catheters. It also allowed the bird to move freely (a few steps) inside the pen and even to lay on its belly or sleep with the bill under the shoulder, as was regularly observed during tracer infusion. The free ends of catheter extensions were brought outside the pen to allow intravenous infusion of isotopic tracers and glucose into one flipper and blood sampling from the other one, from a distance, without disturbing the animal. Once the animal was in the experimental setup, particular care was taken to avoid any further intervention. On the day after the infusion experiment, the equipment was removed, and the penguins were weighed, marked on the chest with nyanzol dye to allow resighting, and released in the colony next to the beach. All the birds used in the study were resighted the following weeks, caught, and weighed. All had restored their BM, which indicates that they had been successfully feeding at sea and that the experiments had no impact on their health.
Infusion protocol and preparation of the infusates. At 0900, a primed constant-rate infusion of labeled glycerol and palmitate was started using a calibrated syringe pump and continued for 8 h (see above). The tracer infusate was prepared daily as described by Wolfe (48) and Turcotte et al. (44) using [2- 3 H]glycerol (Amersham, 40.7 GBq/mmol) and [1- 14 C]palmitate (Amersham, 2.04 GBq/mmol). Delipidated bovine serum albumin (catalog no. A-3803, Sigma) was used as the palmitate carrier. Maybe penguin plasma would have been a more suitable carrier, but under our field conditions we were not confident in preparing plasma with the required sterility. Palmitate is one of the most commonly used FA for measuring NEFA kinetics in mammals: it is the second most abundant NEFA and shows low interindividual variability in its percent contribution to NEFA. The same was observed here for king penguins, and we have determined previously that using palmitate to measure NEFA kinetics in penguins gives realistic estimates of R a NEFA (2) . Even if the absolute R a values obtained with the methodology used cannot be fully ascertained, it is likely that the relative changes of R a on which this study was partly based were correctly determined. Infusion rates of [2- 3 H]glycerol and [1-14 C]palmitate were 215,000 Ϯ 4,000 and 116,000 Ϯ 4,000 dpm ⅐ kg Ϫ1 ⅐ min Ϫ1 , respectively (n ϭ 10), which corresponded to trace amounts of Ͻ0.002% of basal R a glycerol and Ͻ0.03% of basal Ra palmitate. Glucose dissolved in sterile saline was infused at 5 mg ⅐ kg Ϫ1 ⅐ min Ϫ1 using a calibrated syringe pump and the same catheter as for tracers. This dose was determined from preliminary trials as inducing an ϳ2-fold increase in plasma glucose, the maximum glycemia reached (ϳ24 mmol/l) being close to the highest glycemia (28 mmol/l) measured in fasting penguins (19) . Dead volume of the infusion catheter (2.3 ml) and the infusion rate were taken into account to determine the exact time at which glucose infusion actually begun and ended.
Based on data from a previous study (2) , a delay of 135 min separated the beginning of the tracer infusion and the first blood sampling to ensure that a steady state had been reached. Blood samples were taken every 15 min (basal period) and then every 30 min, except during the two last hours when blood was obtained on an hourly basis. Five milliliters of blood was collected at each sampling time, with EDTA used as an anticoagulant. After blood sampling the catheter was flushed with a volume of saline equal to sample volume plus dead volume of the catheter. Saline remaining in the catheter was withdrawn at the onset of the next sampling. Immediately after sampling, the blood was centrifuged and the plasma separated and stored at Ϫ20°C until analysis.
Determination of glycerol and palmitate specific activities. Plasma glycerol and NEFA specific activities were determined as previously described (3, 4) . A 1-ml aliquot of plasma was mixed with chloroform-methanol (2:1, vol/vol). After extraction and evaporation, an aqueous and an organic extract were obtained and resuspended in ethanol-water (1:1, vol/ vol) and hexane-isopropanol (3:2, vol/vol), respectively. A volume of aqueous extract equivalent to 300 l of plasma was used to determine the glycerol concentration. It was dried under nitrogen and resuspended in hydrazine buffer. Glycerol concentration was measured enzymatically. Total tritium activity was counted on another aliquot of aqueous extract equivalent to 150 l of plasma using scintillation fluid (Ecoscint A, National Diagnostics) and a Wallac 1409 counter. At this step of analysis, tritium activity is found only in glycerol and glucose. The percent activity in glycerol was obtained by separating glycerol from glucose using thin-layer chromatography with chloroform-methanol (40:24, vol/vol) as the developing solvent. The glycerol and glucose fractions were resuspended in scintillation fluid for counting. The specific activity of glycerol was calculated as total tritium activity times the fraction of activity in glycerol divided by glycerol concentration.
Total NEFA concentration was measured on 10 l of plasma with an analytic test kit (NEFA C, Wako Chemicals). Palmitate concentration was obtained by multiplying NEFA concentration by the fractional contribution of palmitate to total NEFA, as determined by gas-liquid chromatography. Briefly, an aliquot of the lipid extract was separated by thin-layer chromatography using hexane-diethyl ether-acetic acid (70:30:1, vol/vol/vol) as the developing solvent. The NEFA fraction was isolated and converted to methyl esters using 14% boron trifluoride in methanol. FA methyl esters were separated and quantified using a gas chromatograph (Chrompack CP 9001) equipped with a capillary column (AT-WAX) and a flame ionization detector. The total 14 C activity was counted on an aliquot of the organic extract, and its distribution in plasma lipids [triacylglycerols (TAG), diacylglycerols, NEFA, and phospholipids] was determined after separation of lipids by thin-layer chromatography as described above. Each fraction was resuspended in ethanolwater (1:1, vol/vol) and counted in scintillation fluid (Ecoscint A). Because no 14 C is incorporated in FA other than palmitate, palmitate activity was calculated by multiplying total 14 C activity found in the lipid extract by the fraction of activity in NEFA. Palmitate activity divided by palmitate concentration yielded palmitate specific activity.
Other metabolites and hormones. Plasma glucose and ␤-hydroxybutyrate (␤-OHB) levels were determined on deproteinized plasma by enzymatic methods (Test-Combination, Boehringer-Mannheim). TAG levels were estimated by enzymatic colorimetric methods using a commercial kit (Peridochrom triglycerides GPO-PAP, Boehringer-Mannheim). Radioimmunoassay was used to measure plasma glucagon (GL-32K kit, Linco), insulin (insulin-CT kit, CIS bio international), and corticosterone (DA 200T kit, ICN). All measurements were made in the same run, and the intra-assay coefficient of variation was 5-8%, depending on the hormone. Hormones were measured at the end of each infusion period (basal, glucose, postglucose).
Calculations and statistics. During the basal period, physiological and isotopic steady states were maintained. Glycerol and palmitate Ra were therefore calculated with the steadystate equation of Steele (40): Ra ϭ tracer infusion rate (dpm/ min)/specific activity (dpm/mmol). After glucose infusion, the isotopic steady state was not significantly disrupted, but significant changes in plasma glycerol and palmitate concentrations were observed. In this case, the Ra and the rate of disappearance (Rd) of glycerol and palmitate were calculated using the non-steady-state equations of Steele (40) . Because the distribution volume of glycerol and palmitate is unknown in penguins, calculations were made using the various values reported for mammals. Irrespective of the distribution volume (150-325 ml/kg for glycerol, 40-50 ml/kg for palmitate), at all times of the infusion experiment Ra and Rd were not significantly different from each other or from flux rate values (Rt) calculated using the steady-state equation (P Ͼ 0.05). Consequently, all fluxes are presented as Ra calculated with the steady-state equation and expressed per unit BM. Ra NEFA was determined by dividing Ra palmitate by the fractional contribution of palmitate to total NEFA. This contribution did not change significantly during the infusion experiment (P Ͼ 0.49) and averaged 20.5 Ϯ 0.7%. Ra and Rd were compared with the Wilcoxon signed rank test. The identity of R a and Rt was determined by verifying that the slope of the linear regression between them was not statistically different from unity, as according to Tomassone et al. (41) . Statistical differences of means between the two groups were assessed using the unpaired Student's t-test. Statistical significance of changes induced by glucose infusion was assessed using two-way ANOVA with time and penguins as the main factors. When populations were not normal or homoscedastic, the Mann-Whitney ranked-sum test or Kruskal-Wallis ANOVA on ranks were used. When significant changes were detected with ANOVA, the Student-Newman-Keuls method was used to determine which means were different from basal values. Values are means Ϯ SE. The criterion of significance was P Ͻ 0.05.
RESULTS

Basal values.
Data on plasma levels of hormones and metabolites in the basal state (see below) confirmed our classification of individuals into NSB and SB groups based on the quality of the environment on the day of the experiment (quiet or noisy, respectively). At the time of the experiment, BM was similar in NSB and SB (P Ͼ 0.90) and averaged 11.42 Ϯ 0.13 kg. Compared with NSB, SB had nearly sixfold higher basal plasma levels of glucagon and corticosterone ( , respectively; see Figs. 2B and 3B; P Ͻ 0.001). Basal plasma concentration (see Fig. 2A ) and R a of glycerol (see Fig. 3A ) were also higher (although not significantly; P Ͼ 0.40), and basal glycemia (Fig. 1) slightly lower (9.98 Ϯ 0.13 vs. 12.67 Ϯ 0.09 mmol/l, P Ͻ 0.001) in SB than in NSB. Basal plasma ␤-OHB (see Fig. 4A ), TAG (see Fig. 4B ), and insulin (Table 1) levels were not significantly different between the two groups.
Response to glucose infusion. In the two groups, glucose infusion resulted in a comparable ϳ2-fold progressive increase in plasma glucose (P Ͻ 0.001) followed by a partial and significant (P Ͻ 0.05) return toward basal levels postglucose (Fig. 1 ). During and after glucose infusion, glycemia was not significantly different between the two groups (P Ͼ 0.09). In NSB, the plasma concentration and R a of glycerol and NEFA were not affected by glucose infusion (P Ͼ 0.16; Figs. 2  and 3 ). Throughout the infusion experiment, they averaged 0.06 Ϯ 0.01 and 0.62 Ϯ 0.02 mmol/l for the concentration of glycerol and NEFA, respectively, and 6.85 Ϯ 0.58 and 15.24 Ϯ 0.45 mol ⅐ kg Ϫ1 ⅐ min Ϫ1 for the R a of glycerol and NEFA, respectively. In SB, glucose infusion decreased plasma concentration and R a of glycerol and NEFA by ϳ2.5-fold (P Ͻ 0.001). This effect was significant and maximum as soon as 30 min after the beginning of glucose infusion, when the plasma glucose level (14.67 Ϯ 0.65 mmol/l) was only slightly higher than basal glycemia in NSB (P ϭ 0.046). A tendency for a return toward basal values was observed postglucose, although changes were not significant. During glucose infusion and postglucose, the concentrations and R a of glycerol and NEFA were not significantly different between SB and NSB (P Ͼ 0.07).
Glucose infusion induced a 25 and 64% decrease in plasma ␤-OHB level in NSB and SB, respectively (P Ͻ 0.001; Fig. 4A ). In both groups, the lowest concentrations of ␤-OHB were observed at the end of glucose infusion when glycemia was at the highest, and postglucose. Postglucose, the ␤-OHB level was twice lower in SB than in NSB (P Ͻ 0.001). The plasma TAG level was not affected by glucose infusion in NSB (P Ͼ 0.05; Fig. 4B ) but decreased by 35% in SB (P Ͻ 0.01), reaching postglucose values 1.5 times lower than in NSB (P Ͻ 0.001).
In NSB, plasma corticosterone and insulin remained unchanged during glucose infusion, the twofold decrease in plasma glucagon being nonsignificant (P ϭ 0.44), possibly due to the high variability in the basal state (Table 1 ). In SB, glucose infusion induced 2.8-and 6.5-fold decreases in plasma corticosterone and glucagon, respectively, and an ϳ3-fold increase in insulinemia (P Ͻ 0.05). No further changes were observed postglucose (P Ͼ 0.05). At the end of the glucose infusion and postglucose, the plasma levels of glucagon and insulin were similar in SB and NSB (P Ͻ 0.05), that of corticosterone remaining higher in SB. 
DISCUSSION
NSB and SB.
In this study, we compare the effect of glucose on lipid metabolism in nonstressed and stressed king penguins. In NSB, basal concentrations of the various metabolites and hormones, including corticosterone and glucagon, were similar to those observed in penned, undisturbed, and phase II fasting king penguins (3). Basal lipolytic fluxes were also similar to those reported previously under the same conditions (2, 3). SB birds differed from NSB by sixfold higher basal plasma levels of corticosterone and glucagon and by a basal plasma concentration and R a of NEFA increased by a factor of 2. Corticosterone and glucagon are two major stress hormones in birds (14, 39) , their secretion having been shown to increase in response to various stressors (14, 22) . In the king penguin, a capture and immobilization stress induces an up to 10 times increase in corticosteronemia (26) . Despite the exact role of corticosterone in avian stress response not being well-defined, it is suggested to contribute with glucagon to the mobilization of energy substrates (29, 39) . Thus, in addition to the noise in the vicinity of the birds on the day of the experiment, the hypercorticosteronemia-glucagonemia and the probably related exacerbated lipid mobilization observed in SB birds support the view that they were actually stressed.
Lipolytic response to glucose. In humans, glucose ingestion or intravenous infusion induces a drop in both lipolysis (R a glycerol) and in the release of FA from adipose tissue (R a NEFA). This antilipolytic effect was observed under basal physiological conditions (49) , after an 84-h fast (23) , under euinsulinemic clamp (6), and during exercise (12) . Our results show that the lipolytic response to glucose in the king penguin depends on the metabolic and/or hormonal status of the animal. Glucose infused at 5 mg ⅐ kg Ϫ1 ⅐ min Ϫ1 for 2 h had no antilipolytic effect under normal fasting conditions (NSB), whereas it decreased the plasma concentrations and R a of glycerol and NEFA by more than 2 in SB. These parameters reached minimum values as soon as 30 min after the start of glucose infusion and tended to increase as glycemia decreased postglucose. This result supports the view that the decrease in lipolytic fluxes and plasma concentrations of glycerol and NEFA in SB was not due to a progressive attenuation of stress but to an antilipolytic effect of glucose. To date, lipolytic fluxes had never been measured in birds during glucose infusion. However, in agreement with our results in NSB penguins, glucose intravenous injection or an oral load was shown to have no effect on plasma NEFA in the domestic fowl (21) or the garden warbler (43) under various fasting situations. A decrease in plasma NEFA was observed by Totzke et al. (42) in fasted garden warbler, but the authors did not report if the animals were stressed or not.
In SB, glucose infusion resulted in a significant fall in R a glycerol, which reflects an inhibition of lipolysis. The fact that R a NEFA did not fall more than R a glycerol indicates that primary reesterification (the process where part of the NEFA released by TAG hydrolysis is reesterified back to TAG before entering the circulation) was not stimulated. Thus the decrease in NEFA availability in SB was only related to a reduction of lipolysis. In contrast, in humans, glucose was shown to decrease the mobilization of fat stores by both inhibiting lipolysis and stimulating primary reesterification, this stimulation depending on the rate of glucose infusion (49) . It is possible that larger doses of glucose would have stimulated primary reesterification in stressed fasting king penguins. Because glucose had no antilipolytic effect in NSB, the possibility that it inhibited lipolysis in SB by acting directly on adipose tissue can be excluded. Instead, glucose action may have been indirect through induction of hormonal or metabolic changes. In humans, the lipolytic response to glucose infusion is predominantly mediated by insulin (47) . In birds, insulin has no antilipolytic effect (20) so that the decrease in lipolytic fluxes observed in SB cannot be related to the ϳ3 times increase in plasma insulin level. Rather, the large decrease in plasma glucagon, and perhaps also of corticosterone, that accompanied glucose infusion might explain this antilipolytic effect. Indeed, glucagon is the main lipolytic hormone in birds, including penguins (17, 20) . Its secretion was shown to be inhibited by supplying exogenous glucose in chickens (20) . Corticosterone stimulates lipid fuel mobilization in mammals (34) , but its role in the regulation of lipid metabolism in birds in unclear (38) . The idea that the antilipolytic effect of glucose observed in SB is mediated by the decrease in plasma glucagon and corticosterone is supported by the observation that glucose infusion does not affect either lipolytic fluxes or plasma levels of these hormones in NSB penguins.
Effect of glucose on FA oxidation. Glucose infusion resulted in an inhibition of ketogenesis and hepatic FA oxidation, as reflected by the 1.4-and 2.5-fold decreases in plasma ␤-OHB in NSB and SB, respectively. As the plasma ␤-OHB level is considered to be an index of FA oxidation in fasting penguins (30), we suggest that an increase of glucose availability inhibits (total) FA oxidation in these birds. In NSB, this inhibition occurred whereas lipolysis and NEFA availability remained at basal levels. In accordance with this finding, an increase in the availability of glucose was shown to inhibit FA oxidation in humans, despite the maintenance of FA availability by infusion of lipid and heparin (37) . Our results in fasting king penguins thus support the idea that the availability of glucose, not FAs, is a prime determinant of the substrate mix (glucose vs. fat) that is oxidized for energy production (37) .
The finding that glucose inhibits FA oxidation, without significant changes in the plasma levels of glucagon, corticosterone, and insulin, suggests that it could act directly on FA oxidation in NSB. Accordingly, in humans, glucose is thought to inhibit FA oxidation by restricting entrance of long-chain FA into the mitochondria (33, 45) . The larger decrease in plasma ␤-OHB in SB suggests that FA oxidation was inhibited to a larger extent in these birds than in NSB. The metabolic and hormonal changes observed in SB secondary to glucose infusion may have contributed to this greater inhibition. Glucose infusion resulted in a threefold increase in plasma insulin concentration. In mammals, this hormone is proposed to inhibit FA oxidation throughout enzymatic cascades, leading either to a decreased rate of entry of FA into mitochondria (33) or to the inhibition of enzymes of ␤-oxidation (35) . The glucose-induced decrease of the plasma glucagon also probably contributed to lower FA oxidation in SB. In birds, glucagon stimulates FA oxidation and energy expenditure, as illustrated by the finding that glucagon infusion caused a 1.5-fold increase in plasma ␤-OHB level in long-term fasting king penguins (5) and induced a 47% rise in the metabolic rate of king penguin chicks (1) . FA oxidation and/or the metabolic rate of SB birds may thus have decreased in response to the lowering of the glucagon level induced by glucose. The observation in SB that the plasma TAG level, which reflects hepatic reesterification, decreased in parallel with plasma ␤-OHB suggests that the decrease in hepatic FA oxidation was related to a reduced supply of FA rather than to a reorientation of NEFA toward reesterification. Thus the inhibition of lipolysis, mediated by glucoseinduced lowering of glucagon and corticosterone (see above), certainly contributed to reduce FA oxidation in SB by decreasing NEFA availability (R a NEFA) for oxidative tissues. To sum up, in SB a decrease in total fat oxidation during glucose infusion could be due to concerted reductions in lipolysis, NEFA availability, and FA oxidation by tissues, this response to glucose being direct or mediated by hormonal changes.
Glucose-lipid interactions in stress and fasting. A major finding of this study is that the regulation of metabolic fuel utilization by glucose is affected by stress. While in NSB glucose infusion induced only a moderate reduction in FA oxidation, in SB it induced an important decrease in lipolytic rate, FA oxidation, plasma TAG, glucagon, and corticosterone levels, and an increase in plasma insulin. Therefore it appears necessary to carefully consider whether animals are stressed or not in further field studies on fuel metabolism. It is well-known that the metabolic and hormonal changes observed during stress are directed at provisioning the body with metabolic fuels at a higher rate to face increased energy expenditure (34, 39) . Since in phase II fasting birds and mammals, FAs derived from the hydrolysis of TAG stored in adipose tissue are the main fuel, it is likely that the increased lipolytic rate observed in SB during the basal period was aimed at fueling this high-energy need. Within 30 min after the onset of glucose infusion in SB, the lipolytic rate was markedly depressed, and this infusion induced a decrease in glucagon and corticosterone secretion. These observations demonstrate that during phase II of fasting the stress-induced metabolic and hormonal adjustments can be rapidly reversed by the supply of an alternative fuel.
In birds as in mammals, when a fast is prolonged until a lower threshold in fat stores is reached, animals enter a new fasting state (phase III) corresponding to a simultaneous acceleration in the catabolism of protein and a decrease in the contribution of lipid to energy production (15, 25, 32) . In the king penguin, this shift is associated with an increase in lipolytic rate (2) and in the plasma levels of glucagon (2, 11) and corticosterone (11) , as presently in the basal state of SB, while the resting metabolic rate expressed per kilogram of BM (10, 13) and plasma glucose (11) remain unchanged. These observations lead to the suggestion that the increase in lipolytic rate at the entrance into phase III could contribute to maintaining glycemia by providing glycerol (a gluconeogenic precursor) from TAG hydrolysis rather than supplying the body with more lipid fuels, as likely occurs in phase II fasting SB. Reaching the critical depletion of fat stores characterizing the entrance into phase III is a stressful (emergency) situation that has been observed in animals spontaneously fasting at certain stages of their annual cycle (7, 18, 30) . Other stressful situations such as food shortage, bad weather conditions, predation, and anthropic disturbances can be encountered by wild animals (46) . Present data for phase II fasting king penguins and previous findings for phase III suggest that the metabolic and hormonal way animals adjust to stress would depend on the type and/or amount of endogenous and/or exogenous fuel substrates available.
Perspectives
Using the king penguin as an animal model, this study shows that glucose is a factor regulating lipid metabolism in birds. Depending on the metabolic and hormonal status of the animals, glucose seems to control lipid metabolism through concerted variations of lipolysis, NEFA availability, and FA oxidation. These changes in lipid metabolism could be due to a direct action of glucose on FA oxidation or could be mediated by alterations of the levels of glucagon, corticosterone, and insulin, the main hormones regulating lipid and/or carbohydrate metabolism in birds. This study also suggests that, as in mammals, the availability of glucose, not of FAs, controls substrate metabolism in birds. This notion could help to explain the metabolic and hormonal changes related to stress, prolonged fasting, or other physiological situations in birds (migration, molt). Further support for this notion should arise from the determination of the relative importance of glucose and FA in energy metabolism under these diverse physiological situations. This requires the development of devices and methodologies that allow the measurement of substrate oxidation in field conditions in birds and more generally in wild animals.
